Gerresheimer Lohr GmbH
Location
Bayern
Founded
1901-01-01
Website
Risk Signals
1201 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Glass Containers, Laboratory Apparatus and Furniture, Professional Equipment and Supplies, Not Elsewhere Classified, Durable Goods, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Gerresheimer Lohr GmbH
Live alerts from global media, monitored by Business Radar
2025-01-07 (wallstreet-online.de)
WARBURG RESEARCH upgrades GERRESHEIMER AG to 'Buy' - January 7, 2025
January 7, 2025 - The analysis house Warburg Research has lowered the price target for Gerresheimer from 131 to 113 euros and left the rating at 'Buy'. The latest study on the Novo Nordisk drug Cagrisema has only a limited impact on the sales development of ...
Read more
2024-10-05 (ondrugdelivery.com)
COMPREHENSIVE TESTING PROVES DESIGN CONCEPT OF NOVEL AUTOINJECTOR PLATFORM
Farid Seddighi, Sigrid Saaler-Reinhardt and Daniel Primavessy discuss the critical importance of testing at an early stage of medical device development, presenting an overview of the results that confirm the technical performance and usability of the novel Gx Inbeneo® autoinjector.
Read more
2024-10-03 (kapitalerhoehungen.de)
Vidac Pharma, BioNTech, Gerresheimer optimize the value chain - from research to patients
Medical innovations and rapid therapy development are rapidly gaining momentum thanks to the use of AI. Companies in the pharmaceutical and biotech industries rely on groundbreaking technologies and strategies to optimize the value chain from research to the patient. Vidac Pharma
Read more
2024-10-01 (wallstreet-online.de)
DEUTSCHE BANK RESEARCH upgrades GERRESHEIMER AG to 'Buy'
October 1, 2024 - Deutsche Bank Research has lowered the price target for Gerresheimer from 130 to 110 euros, but left the rating at 'Buy'. Analyst Falko Friedrichs sees an attractive buying opportunity as a result of the price slide following the forecast cuts. The ...
Read more
2024-09-27 (packaging-gateway.com)
New alliance to expedite market adoption of RTU vials and cartridges
Gerresheimer has joined forces with Stevanato and SCHOTT Pharma to expedite the market adoption of ready-to-use (RTU) vials and cartridges.
Read more
2024-09-06 (ondrugdelivery.com)
THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE
Simon Bürdel and Reza Abedian, discuss the importance and value of conducting human factors studies and user consultations above and beyond regulatory requirements when designing user-centric devices for subcutaneous self-injection in at-home settings.
Read more
2024-08-24 (agninews.co.in)
Double Chamber Syringe Market Size And Forecast Strategic Planning: Effective Business Models – அக்னி செய்திகள்
Double Chamber Syringe Market 2024-2032: Innovation and Strategic Growth Opportunities
Read more
2024-07-16 (ondrugdelivery.com)
FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS
Michael Wiglenda describes Gerresheimer’s approach to the industrialisation of drug delivery devices, using the production of the company’s Gx Inbeneo® cartridge-based autoinjector as an example.
Read more
2024-05-15 (pharmaceutical-technology.com)
Sensile Medical Develops Micro-Infusion Pump for EVER Pharma
Sensile Medical has developed a wearable micro-infusion pump for EVER Pharma under the brand name D-mine®. The pump recently received…
Read more